JACOB JACOBY: Open Payments
NPI 1174648232 · BAYONNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 13 payments from 6 companies in 2025. Trend: 2023 $258 · 2024 $307 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $109 |
| Vanda Pharmaceuticals Inc. | 3 | $50 |
| Alkermes, Inc. | 1 | $22 |
| Neos Therapeutics, LP | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
Products named: CAPLYTA, FANAPT, ARISTADA, EXXUA, AUSTEDO XR, HETLIOZ, VRAYLAR.
Industry payments across NJ — which companies pay providers there.
